TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Promega Biotech AB
Closing information (x1000 EUR)
| Closing information | 2024/03 | 2023/03 | 2022/03 |
| Turnover |
8,414
|
7,791
|
8,053 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,153
|
1,118
|
653 |
| EBITDA |
1,160
|
1,133
|
675 |
| Total assets |
3,196
|
3,788
|
3,366 |
| Current assets |
3,183
|
3,769
|
3,332 |
| Current liabilities |
1,169
|
897
|
1,221 |
| Equity capital |
1,765
|
2,654
|
1,937 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
10
|
10
|
10 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Solvency |
55.2%
|
70.1%
|
57.5% |
| Turnover per employee |
841
|
779
|
805 |
| Profit as a percentage of turnover |
13.7%
|
14.3%
|
8.1% |
| Return on assets (ROA) |
36.1%
|
29.5%
|
19.4% |
| Current ratio |
272.3%
|
420.2%
|
272.9% |
| Return on equity (ROE) |
65.3%
|
42.1%
|
33.7% |
| Change turnover |
791
|
408
|
732 |
| Change turnover % |
10%
|
6%
|
10% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.